Financial Decision Intelligence (FDI) brings proactive insights and conversational AI directly into the trusted Strata platform, powered by StrataSignal™, and built on the healthcare financial data, definitions, and security you already rely on.
AI proactively surfaces and prioritizes the financial changes that deserve attention, so teams stop searching reports for what matters.
Noise → AttentionInvestigate changes with conversational AI, explore the drivers, and get to trusted answers faster.
Data → UnderstandingCombine financial and encounter-level data for daily service-line volume predictions and a view of where month-end results are likely to land.
Results → ForesightMore capacity for Finance to partner with operational leaders, evaluate opportunities, and guide decisions.
Capacity → ImpactPick a scenario to see how Command Center flags what matters and Ask Strata gets to the driver. Illustrative examples.
Priority insights surface on their own, so margin drift gets noticed before anyone goes looking for it.
Forecast OP visits are projected to stay about 5% below prior year if the current trend holds.
OP VisitsPerformanceVariance Drivers
| Service Line | Actual | Prior Year | Variance |
|---|---|---|---|
| Orthopedics | 8,140 | 8,696 | −556 / −6.4% |
| General Surgery | 5,410 | 5,480 | −70 / −1.3% |
| Cardiology | 6,920 | 6,975 | −55 / −0.8% |
Key Drivers Total joint replacement down 340 cases, the largest contributor to the Orthopedics decline.
Show me margin for Orthopedics vs. prior year.
Ask in plain language and trace the cause through governed cost and contract data.
Show me direct margin and case volume for Orthopedics vs. prior year.
Thinking complete · Scope: Orthopedics, all entities · Sources: Cost AccountingContract AnalyticsIAR
| Period | Margin | Cases |
|---|---|---|
| FY26 YTD | $14.2M (28.4%) | 8,140 |
| FY25 YTD | $16.1M (32.6%) | 8,696 |
Show the top 3 joint implant vendors by spend increase this year.
Suggested Follow-upsWhat are the outliers in implant cost per case by physician for hips and knees?
FindingImplant price increases from a single vendor, not clinical volume, are driving most of the Orthopedics margin decline.
A generic AI assistant can only summarize the spreadsheet you hand it. It can't watch margin drift on its own or trace it through governed cost and contract data to one vendor. Manually, that trace means pulling cost accounting, contract files, and vendor invoices separately over days.
Persistent overruns are flagged and prioritized, with the financial impact already quantified.
Forecast Premium pay is projected to stay above the volume-adjusted target for the coming pay periods without intervention.
| Entity | Reported | vs Target |
|---|---|---|
| Medical Center A | $610,086 | +$302.8K / +99% |
| Medical Center B | $198,420 | +$41.2K / +26% |
Which cost centers are carrying the overage?
Separate volume, rate, and mix, then drill into the drivers in one place.
How much of this month’s premium pay overage is above the volume-adjusted flex target?
Thinking complete · Scope: Labor & Workforce, current month · Sources: Payroll / LaborBudget LedgerIAR
Which departments or cost centers are carrying the premium pay overage?
| Department | Premium Pay | vs Flex |
|---|---|---|
| Emergency Dept. | $184,200 | +$91.4K |
| Surgical Services | $156,900 | +$78.6K |
| Medical/Surgical Units | $129,300 | +$62.1K |
Suggested Follow-upsIs the overage in Emergency Dept. driven by overtime, agency, or shift differentials?
FindingLabor expense has exceeded its volume-adjusted target for a fifth straight pay period, driven by open positions filled with overtime and premium-rate labor.
Understanding an overrun often starts with the trial balance and journal entry detail, then digging through AP, purchase orders, payroll, and other sources. With Ask Strata that information is connected, so Finance can move from variance to underlying drivers across the P&L in one place.
Mix shifts and net revenue pressure show up as prioritized signals, not buried in a report.
Forecast Net revenue per discharge is projected at $14,016 (−3%) if the current mix trend continues.
| Signal | Value (MTD) | vs. |
|---|---|---|
| Inpatient Commercial Mix Erosion | 23.0% | Prior Year (26.4%) |
| Inpatient Net Revenue per Discharge | $14,450 | Projected $14,016 / Per Case (−3%) |
How has commercial mix trended against prior year?
Connect payer, contract, case mix, and reimbursement detail without a manual data pull.
How has inpatient commercial payer mix trended against prior year?
Thinking complete · Scope: Inpatient · Sources: Patient AccountingPayer ContractsIAR
| Payer Class | Current Mix | Prior Year | Variance |
|---|---|---|---|
| Commercial | 23.0% | 26.4% | −3.4 pts |
| Medicare / Medicaid | 58.5% | 56.0% | +2.5 pts |
What’s the effect on net revenue per encounter, with case mix held steady?
| Metric | Current | vs. |
|---|---|---|
| Inpatient Net Revenue per Discharge | $14,450 | Projected $14,016 / Per Case (−3%) |
Suggested Follow-upsBreak down inpatient commercial mix erosion by service line or location.
FindingInpatient commercial mix erosion, not acuity or rate, is flowing straight through to net revenue per encounter.
This analysis traditionally means bringing together detailed encounter and reimbursement data, then working through payer and contract differences. Ask Strata connects that detail, so Finance can see which payers, contracts, services, and patient populations are driving the change and quantify the impact.
Shaped with about 50 senior finance leaders across 35 health systems
“We were on week 2 of waiting for data from oncology, but we got it in 2 minutes with Ask Strata.”
“I thought it was pretty impressive how you've got key drivers, and it explains how that metric came to be.”